1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 RESIDUE PRO 13 IS A CIS PROLINE. Guntert, P. Williamson, M.P. Havel, T.F. Wuthrich, K. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C5 H7 N O3 129.114 n PYROGLUTAMIC ACID L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK J.Mol.Biol. JMOBAK 0070 0022-2836 182 295 315 10.1016/0022-2836(85)90347-X 3839023 Solution conformation of proteinase inhibitor IIA from bull seminal plasma by 1H nuclear magnetic resonance and distance geometry. 1985 UK J.Mol.Biol. JMOBAK 0070 0022-2836 173 341 Secondary Structure in the Solution Conformation of the Proteinase Inhibitor IIA from Bull Seminal Plasma by Nuclear Magnetic Resonance 1984 UK J.Mol.Biol. JMOBAK 0070 0022-2836 166 641 Assignment of the 1H Nuclear Magnetic Resonance Spectrum of the Proteinase Inhibitor IIA from Bull Seminal Plasma by Two-Dimensional Nuclear Magnetic Resonance at 500 Mhz 1983 UK J.Mol.Biol. JMOBAK 0070 0022-2836 166 631 Characterization of the Proteinase Inhibitor IIA from Bull Seminal Plasma by 1H Nuclear Magnetic Resonance. Stability, Amide Proton Exchange and Mobility of Aromatic Residues 1983 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 6191.089 PROTEINASE INHIBITOR IIA 1 man polymer no yes (PCA)GAQVDCAEFKDPKVYCTRESNPHCGSNGETYGNKCAFCKAVMKSGGKINLKHRGKC QGAQVDCAEFKDPKVYCTRESNPHCGSNGETYGNKCAFCKAVMKSGGKINLKHRGKC A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n cattle Bos sample 9913 Bos taurus pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list struct_conf struct_conf_type entity_poly pdbx_struct_mod_residue struct_conn repository Initial release Version format compliance Version format compliance Derived calculations Other Derived calculations Polymer sequence 1 0 1991-04-15 1 1 2008-03-24 1 2 2011-07-13 1 3 2017-11-29 2 0 2019-12-25 _pdbx_database_status.process_site _entity_poly.pdbx_seq_one_letter_code_can _pdbx_struct_mod_residue.parent_comp_id _struct_conn.pdbx_leaving_atom_flag Y BNL 1990-05-14 REL REL 5 PCA 1 n 1 PCA 1 A GLY 2 n 2 GLY 2 A ALA 3 n 3 ALA 3 A GLN 4 n 4 GLN 4 A VAL 5 n 5 VAL 5 A ASP 6 n 6 ASP 6 A CYS 7 n 7 CYS 7 A ALA 8 n 8 ALA 8 A GLU 9 n 9 GLU 9 A PHE 10 n 10 PHE 10 A LYS 11 n 11 LYS 11 A ASP 12 n 12 ASP 12 A PRO 13 n 13 PRO 13 A LYS 14 n 14 LYS 14 A VAL 15 n 15 VAL 15 A TYR 16 n 16 TYR 16 A CYS 17 n 17 CYS 17 A THR 18 n 18 THR 18 A ARG 19 n 19 ARG 19 A GLU 20 n 20 GLU 20 A SER 21 n 21 SER 21 A ASN 22 n 22 ASN 22 A PRO 23 n 23 PRO 23 A HIS 24 n 24 HIS 24 A CYS 25 n 25 CYS 25 A GLY 26 n 26 GLY 26 A SER 27 n 27 SER 27 A ASN 28 n 28 ASN 28 A GLY 29 n 29 GLY 29 A GLU 30 n 30 GLU 30 A THR 31 n 31 THR 31 A TYR 32 n 32 TYR 32 A GLY 33 n 33 GLY 33 A ASN 34 n 34 ASN 34 A LYS 35 n 35 LYS 35 A CYS 36 n 36 CYS 36 A ALA 37 n 37 ALA 37 A PHE 38 n 38 PHE 38 A CYS 39 n 39 CYS 39 A LYS 40 n 40 LYS 40 A ALA 41 n 41 ALA 41 A VAL 42 n 42 VAL 42 A MET 43 n 43 MET 43 A LYS 44 n 44 LYS 44 A SER 45 n 45 SER 45 A GLY 46 n 46 GLY 46 A GLY 47 n 47 GLY 47 A LYS 48 n 48 LYS 48 A ILE 49 n 49 ILE 49 A ASN 50 n 50 ASN 50 A LEU 51 n 51 LEU 51 A LYS 52 n 52 LYS 52 A HIS 53 n 53 HIS 53 A ARG 54 n 54 ARG 54 A GLY 55 n 55 GLY 55 A LYS 56 n 56 LYS 56 A CYS 57 n 57 CYS 57 A author_defined_assembly 1 monomeric A PCA 1 PYROGLUTAMIC ACID A PCA 1 GLN 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 3 A A NH1 OXT ARG CYS 54 57 1.99 1 A ARG 19 0.266 SIDE CHAIN 1 A HIS 24 0.109 SIDE CHAIN 1 A HIS 53 0.217 SIDE CHAIN 1 A ARG 54 0.201 SIDE CHAIN 2 A ARG 19 0.253 SIDE CHAIN 2 A HIS 24 0.173 SIDE CHAIN 2 A ARG 54 0.302 SIDE CHAIN 3 A HIS 53 0.161 SIDE CHAIN 3 A ARG 54 0.272 SIDE CHAIN 4 A ARG 19 0.206 SIDE CHAIN 4 A ARG 54 0.295 SIDE CHAIN 5 A ARG 19 0.152 SIDE CHAIN 5 A ARG 54 0.301 SIDE CHAIN 1 -11.55 1.80 110.60 99.05 A A A N CA CB TYR TYR TYR 16 16 16 N 1 6.89 1.10 114.20 121.09 A A A CA CB SG CYS CYS CYS 17 17 17 N 1 -4.09 0.60 121.00 116.91 A A A CB CG CD2 TYR TYR TYR 32 32 32 N 1 3.74 0.60 121.00 124.74 A A A CB CG CD1 TYR TYR TYR 32 32 32 N 1 11.65 1.50 110.80 122.45 A A A N CA CB CYS CYS CYS 36 36 36 N 2 -4.30 0.70 120.80 116.50 A A A CB CG CD1 PHE PHE PHE 10 10 10 N 2 -17.00 1.90 110.10 93.10 A A A CB CA C SER SER SER 27 27 27 N 2 18.61 2.70 111.00 129.61 A A A N CA C ASN ASN ASN 50 50 50 N 3 -16.58 1.90 110.10 93.52 A A A CB CA C SER SER SER 27 27 27 N 3 14.01 1.50 110.50 124.51 A A A N CA CB SER SER SER 27 27 27 N 3 15.11 2.10 120.10 135.21 A A A CA C O SER SER SER 27 27 27 N 3 -14.45 2.20 117.20 102.75 A A A CA C N SER SER ASN 27 27 28 Y 2 A A CA CB SER SER 27 27 0.098 0.015 1.525 1.623 N 3 A A CA CB SER SER 27 27 0.098 0.015 1.525 1.623 N 1 A GLN 4 -97.84 52.43 1 A VAL 5 -102.34 40.41 1 A LYS 11 -65.03 -74.67 1 A VAL 15 -109.20 -86.89 1 A THR 18 51.49 -82.46 1 A ASN 22 170.15 103.45 1 A PRO 23 -69.88 94.81 1 A SER 27 -48.23 -79.98 1 A ASN 28 -147.74 33.60 1 A TYR 32 -154.76 -141.92 1 A LYS 44 -90.49 51.71 1 A LYS 48 -147.45 21.88 1 A HIS 53 -47.15 -11.02 2 A ALA 3 71.28 -86.98 2 A GLN 4 75.56 -5.91 2 A CYS 7 -108.62 47.62 2 A LYS 11 -94.11 47.97 2 A ASP 12 -42.63 160.93 2 A LYS 14 171.03 -36.94 2 A THR 18 -124.20 -85.35 2 A ARG 19 -128.46 -155.81 2 A ASN 22 70.17 129.54 2 A SER 27 -114.85 -163.38 2 A CYS 36 -62.36 -71.04 2 A MET 43 -55.76 -78.18 2 A LYS 44 -91.47 53.36 2 A SER 45 -75.06 -74.01 2 A LYS 48 -172.67 124.58 2 A LYS 52 -106.50 -96.00 3 A ALA 3 -174.94 62.05 3 A ASP 6 -159.23 82.95 3 A THR 18 -83.52 -75.40 3 A ARG 19 -100.14 63.24 3 A GLU 20 -46.85 171.44 3 A SER 21 -101.95 74.89 3 A ASN 22 -41.38 171.31 3 A PRO 23 5.04 92.08 3 A CYS 25 -64.86 -172.96 3 A ASN 28 -162.81 -54.72 3 A LYS 48 178.57 146.27 3 A LEU 51 48.37 109.92 3 A ARG 54 -44.29 165.11 4 A ALA 3 75.35 -1.25 4 A GLN 4 47.21 -165.92 4 A CYS 7 -123.93 -57.86 4 A LYS 11 -79.07 -87.86 4 A PRO 13 -104.53 -60.91 4 A VAL 15 29.78 91.85 4 A CYS 17 -152.86 61.34 4 A THR 18 -165.29 42.18 4 A SER 21 -148.91 41.03 4 A SER 27 -43.10 -85.63 4 A ASN 28 -140.57 30.60 4 A GLU 30 -160.24 -160.18 4 A LYS 44 -87.29 -78.26 4 A SER 45 26.75 36.16 4 A LEU 51 -54.10 -179.09 4 A LYS 52 163.16 108.77 4 A HIS 53 -48.36 -130.53 5 A ALA 3 59.23 174.46 5 A CYS 7 -106.54 -67.93 5 A LYS 11 -90.48 36.62 5 A ASP 12 -44.69 -74.96 5 A PRO 13 -103.64 -135.86 5 A LYS 14 104.58 43.21 5 A ARG 19 -142.10 -115.24 5 A SER 21 -145.15 38.45 5 A ASN 22 49.14 143.37 5 A ASN 28 -160.63 -53.40 5 A SER 45 27.58 -81.42 5 A LYS 48 74.72 104.22 5 A ILE 49 -142.12 51.95 5 A LYS 52 -151.48 -81.05 PROTEINASE INHIBITOR IIA (BUSI IIA) (NMR, 5 DISTANCE CONSTRAINED STRUCTURES) SOLUTION CONFORMATION OF PROTEINASE INHIBITOR IIA FROM BULL SEMINAL PLASMA BY 1H NUCLEAR MAGNETIC RESONANCE AND DISTANCE GEOMETRY 1 Y N A ASN 34 A ASN 34 HELX_P ALPHA HELIX A SER 45 A SER 45 1 H1 12 disulf 2.110 A CYS 7 A SG CYS 7 1_555 A CYS 39 A SG CYS 39 1_555 disulf 1.990 A CYS 17 A SG CYS 17 1_555 A CYS 36 A SG CYS 36 1_555 disulf 1.973 A CYS 25 A SG CYS 25 1_555 A CYS 57 A SG CYS 57 1_555 covale 1.326 both A PCA 1 A C PCA 1 1_555 A GLY 2 A N GLY 2 1_555 PROTEINASE INHIBITOR PROTEINASE INHIBITOR A ASP 12 A ASP 12 1 A PRO 13 A PRO 13 -0.02 A ASP 12 A ASP 12 2 A PRO 13 A PRO 13 0.12 A ASP 12 A ASP 12 3 A PRO 13 A PRO 13 -0.02 A ASP 12 A ASP 12 4 A PRO 13 A PRO 13 0.22 A ASP 12 A ASP 12 5 A PRO 13 A PRO 13 0.02 IAC2_BOVIN UNP 1 1 P01001 QGAQVDCAEFKDPKVYCTRESNPHCGSNGETYGNKCAFCKAVMKSGGKINLKHRGKC 2 57 1BUS 2 57 P01001 A 1 2 57 3 anti-parallel anti-parallel A GLY 29 A GLY 29 A GLY 33 A GLY 33 A PRO 23 A PRO 23 A SER 27 A SER 27 A ASN 50 A ASN 50 A GLY 55 A GLY 55 1 P 1